"use strict";(self.webpackChunkdocs=self.webpackChunkdocs||[]).push([[123],{3959:(e,n,t)=>{t.r(n),t.d(n,{assets:()=>l,contentTitle:()=>r,default:()=>h,frontMatter:()=>i,metadata:()=>o,toc:()=>c});var s=t(4848),a=t(8453);const i={output:"docusaurus-md",sidebar_position:4,description:"An example from Belman et al. (2020) showing a complex model with age-dependent relative risks."},r="4) Breast cancer and BRCA1 {#breast-cancer-and-brca1}",o={id:"examples/example4",title:"4) Breast cancer and BRCA1",description:"An example from Belman et al. (2020) showing a complex model with age-dependent relative risks.",source:"@site/docs/examples/example4.md",sourceDirName:"examples",slug:"/examples/example4",permalink:"/shinyseg/examples/example4",draft:!1,unlisted:!1,tags:[],version:"current",sidebarPosition:4,frontMatter:{output:"docusaurus-md",sidebar_position:4,description:"An example from Belman et al. (2020) showing a complex model with age-dependent relative risks."},sidebar:"tutorialSidebar",previous:{title:"3) Two phenotypes",permalink:"/shinyseg/examples/example3"}},l={},c=[{value:"Pedigree table",id:"pedigree-table",level:2},{value:"Penetrance",id:"penetrance",level:2},{value:"FLB",id:"flb",level:2}];function d(e){const n={a:"a",code:"code",em:"em",h1:"h1",h2:"h2",li:"li",p:"p",pre:"pre",strong:"strong",ul:"ul",...(0,a.R)(),...e.components};return(0,s.jsxs)(s.Fragment,{children:[(0,s.jsx)(n.h1,{id:"breast-cancer-and-brca1",children:"4) Breast cancer and BRCA1"}),"\n",(0,s.jsxs)(n.p,{children:["This example is directly taken from ",(0,s.jsx)(n.a,{href:"https://doi.org/10.1038/s41436-020-0920-4",children:"Belman et\nal.\xa0(2020)"}),". It puts to the\ntest shinyseg\u2019s more advanced capabilities by requiring a penetrance\nmodel with age-dependent relative risks and the explicit declaration of\nunobserved phenotypes."]}),"\n",(0,s.jsx)(n.h2,{id:"pedigree-table",children:"Pedigree table"}),"\n",(0,s.jsx)(n.p,{children:"The data corresponding to the case is shown below:"}),"\n",(0,s.jsx)(n.pre,{children:(0,s.jsx)(n.code,{className:"language-text",children:" ped id fid mid sex phenotype carrier proband age\n   1  1   0   0   1    nonaff       .       .  80\n   1  2   0   0   2      BrCa       .       .  65\n   1  3   1   2   2      BrCa     het       .  81\n   1  4   1   2   1    nonaff       .       .  41\n   1  5   0   0   2         .       .       .  89\n   1  6   0   0   1    nonaff       .       .  80\n   1  7   1   2   2    nonaff     het       .  75\n   1  8   1   2   2    nonaff     neg       .  60\n   1  9   4   5   2      BrCa     het       .  41\n   1 10   4   5   2      BrCa     het       .  50\n   1 11   4   5   2    nonaff     het       .  52\n   1 12   6   7   2      BrCa     het       1  49\n   1 13   6   7   1    nonaff     het       .  36\n   1 14   6   7   2      BrCa     het       .  48\n"})}),"\n",(0,s.jsx)("img",{src:t(5832).A,style:{maxHeight:"350px"}}),"\n",(0,s.jsx)(n.p,{children:"Notice how the legend also includes ovarian and pancreatic cancer, even\nthough these are not present in any of the members of the pedigree. This\nis because they are still relevant for computing the penetrances and\ntherefore must be included in the analysis. The next section explains\nhow to do so."}),"\n",(0,s.jsx)(n.h2,{id:"penetrance",children:"Penetrance"}),"\n",(0,s.jsxs)(n.p,{children:["This analysis employs the default ",(0,s.jsx)(n.code,{children:"Relative risk"})," mode and autosomal\ndominant (",(0,s.jsx)(n.code,{children:"AD"}),") inheritance. It\u2019s important to note that when uploading\nprevious data to the app, the relative risk table will only include a\nrow corresponding to breast cancer (",(0,s.jsx)(n.code,{children:"BrCa"}),") for both sexes."]}),"\n",(0,s.jsx)("img",{src:t(7797).A,style:{maxHeight:"400px"}}),"\n",(0,s.jsxs)(n.p,{children:["As mentioned, in this case it\u2019s necessary to include other relevant\nphenotypes for calculating the penetrance for the specific gene under\nanalysis (BRCA1). This can be achieved by entering their names into the\n",(0,s.jsx)(n.strong,{children:"Extra phenotypes"})," input, located at the bottom of the ",(0,s.jsx)(n.em,{children:"Penetrance"}),"\npanel. Additionally, we need to specify sex-specific penetrances. This\ncan be easily done by clicking on the entries of the sex column and\nchanging ",(0,s.jsx)(n.code,{children:"both"})," to any of the sexes. With that done, the table will look\nlike this:"]}),"\n",(0,s.jsx)("img",{src:t(4535).A,style:{maxHeight:"600px"}}),"\n",(0,s.jsxs)(n.p,{children:["We are now ready to start filling in the data, using similar estimates\nto those in ",(0,s.jsx)(n.a,{href:"https://doi.org/10.1038/s41436-020-0920-4",children:"Belman et\nal.\xa0(2020)"}),":"]}),"\n",(0,s.jsxs)(n.ul,{children:["\n",(0,s.jsxs)(n.li,{children:["\n",(0,s.jsxs)(n.p,{children:["For the baseline parameters (",(0,s.jsx)(n.code,{children:"neg risk"}),", ",(0,s.jsx)(n.code,{children:"neg mean"}),", ",(0,s.jsx)(n.code,{children:"neg SD"}),"), we\nhave utilized the UK 2008-2012 estimates from Cancer Incidence in\nFive Continents (CI5). While not strictly necessary, in this case\nthe data were fitted to the normal model employed by shinyseg to\nobtain the optimal parameters. This may be done using the\n",(0,s.jsx)(n.a,{href:"../how-to/penetrance#optimal-parameters",children:(0,s.jsx)(n.strong,{children:"Assistant"})}),"."]}),"\n"]}),"\n",(0,s.jsxs)(n.li,{children:["\n",(0,s.jsxs)(n.p,{children:["The ",(0,s.jsx)(n.code,{children:"hazard ratios(s)"})," have also been adapted from ",(0,s.jsx)(n.a,{href:"https://fenglab.chpc.utah.edu/cool2/manual.html",children:"COOL\u2019s\nwebsite"}),". The\nvectors shown below are of length six, corresponding to the hazard\nratios at ages approximately 1, 20, 40, 60, 80, and 100. These are\nthen interpolated/smoothed by the app, as shown in the plots below\nthe table."]}),"\n"]}),"\n"]}),"\n",(0,s.jsx)("img",{src:t(4920).A,style:{maxHeight:"600px"}}),"\n",(0,s.jsx)(n.h2,{id:"flb",children:"FLB"}),"\n",(0,s.jsxs)(n.p,{children:["Finally, we can ",(0,s.jsx)(n.strong,{children:"Calculate"})," the Bayes factor, which in this case\npoints to inconclusive evidence for pathogenicity. While this conclusion\naligns with that of ",(0,s.jsx)(n.a,{href:"https://doi.org/10.1038/s41436-020-0920-4",children:"Belman et\nal.\xa0(2020)"}),", we note a slight\nquantitative deviation (5.7 vs.\xa03.9) which is primarily attributed to\nhow shinyseg utilizes model-based estimates instead of the raw data. The\npayoff of shinyseg\u2019s set up is that sensitivity analyses can now be\neasily performed by altering a reasonable number of parameters."]}),"\n",(0,s.jsx)("img",{src:t(4083).A,style:{maxHeight:"150px"}})]})}function h(e={}){const{wrapper:n}={...(0,a.R)(),...e.components};return n?(0,s.jsx)(n,{...e,children:(0,s.jsx)(d,{...e})}):d(e)}},4083:(e,n,t)=>{t.d(n,{A:()=>s});const s=t.p+"assets/images/ex4-flb-864b241d42e875f590e979a2ea7c8203.png"},5832:(e,n,t)=>{t.d(n,{A:()=>s});const s=t.p+"assets/images/ex4-ped-1d4a1562afb9372e0d95c59c3d6d3163.png"},7797:(e,n,t)=>{t.d(n,{A:()=>s});const s=t.p+"assets/images/ex4-rrisk-tab1-36d89df57fe257762e2145cc20cc6bdf.png"},4535:(e,n,t)=>{t.d(n,{A:()=>s});const s=t.p+"assets/images/ex4-rrisk-tab3-9d7f0c96dbc94f282d8079d5d7319307.png"},4920:(e,n,t)=>{t.d(n,{A:()=>s});const s=t.p+"assets/images/ex4-rrisk-tab4-5e0c860e2ccbc3d6580697ecc13c0385.png"},8453:(e,n,t)=>{t.d(n,{R:()=>r,x:()=>o});var s=t(6540);const a={},i=s.createContext(a);function r(e){const n=s.useContext(i);return s.useMemo((function(){return"function"==typeof e?e(n):{...n,...e}}),[n,e])}function o(e){let n;return n=e.disableParentContext?"function"==typeof e.components?e.components(a):e.components||a:r(e.components),s.createElement(i.Provider,{value:n},e.children)}}}]);